Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Broad Center for Mendelian Genomics, |
RCV002789957 | SCV003761106 | uncertain significance | Hermansky-Pudlak syndrome 4 | 2023-01-24 | criteria provided, single submitter | curation | The p.Gln516Ter variant in HPS4 has been reported in 1 individual, in the compound heterozygous state, with Hermansky-Pudlak syndrome 4 (PMID: 31898847) and has been identified in 0.002% (2/113762) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs372833027). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This nonsense variant leads to a premature termination codon at position 516, which is predicted to lead to a truncated or absent protein. Loss of function of the HPS4 gene is strongly associated to autosomal recessive Hermansky-Pudlak syndrome 4. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PVS1_strong, PM2_supporting (Richards 2015). |
Labcorp Genetics |
RCV003108234 | SCV003782828 | pathogenic | not provided | 2023-07-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln516*) in the HPS4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS4 are known to be pathogenic (PMID: 12664304). This variant is present in population databases (rs372833027, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Hermansky–Pudlak syndrome (PMID: 31898847). ClinVar contains an entry for this variant (Variation ID: 2412666). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV002789957 | SCV005059733 | pathogenic | Hermansky-Pudlak syndrome 4 | 2024-02-17 | criteria provided, single submitter | clinical testing |